ORBIMED ADVISORS LLC

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 7,918,163 shares
Security Ownership %: 13%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)

17 Jun 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,918,163 shares of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN). This represents 13% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	13%		$140,468,212	7,918,163			$17.74	13D/A	16 Jun 2025	17 Jun 2025, 17:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.6%	0%	$122,576,885	7,959,538	0		$15.40	Q4 2025
30 Sep 2025	3.9%	0%	$162,931,743	7,959,538	0		$20.47	Q3 2025
30 Jun 2025	4%	0%	$159,668,332	7,959,538	0		$20.06	Q2 2025
31 Mar 2025	3.8%	0%	$156,643,708	7,959,538	0		$19.68	Q1 2025
31 Dec 2024	3.7%	0%	$179,089,605	7,959,538	0		$22.50	Q4 2024
30 Sep 2024	3.7%	0%	$203,286,601	7,959,538	0		$25.54	Q3 2024
30 Jun 2024	4%	-0.48%	$186,014,403	7,959,538	-1,038,800	-12%	$23.37	Q2 2024
31 Mar 2024	3.1%	0%	$158,280,765	8,998,338	0		$17.59	Q1 2024
31 Dec 2023	2.5%	0%	$124,536,998	8,998,338	0		$13.84	Q4 2023
30 Sep 2023	2.8%	0%	$122,917,297	8,998,338	0		$13.66	Q3 2023
30 Jun 2023	3.6%	+0%	$183,656,079	8,998,338	+2,125	+0.02%	$20.41	Q2 2023
31 Mar 2023	3.9%	+3.9%	$197,017,065	8,996,213	+8,996,213	NEW	$21.90	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.